Prognostic implications of BAX protein expression and microsatellite instability in all non-metastatic stages of primary colon cancer treated by surgery alone

International Journal of Colorectal Disease

Volumn 24, Issue 6, 2009, Pages 655-663

  Nehls, Oliver ^a   Hass, Holger G ^a   Okech, Thomas ^a   Zenner, Silke ^a   Hsieh, Chih Jen ^a   Sarbia, Mario ^b   Borchard, Franz ^c   Gruenagel, Hans Helmut ^d   Gaco, Vera ^a   Porschen, Rainer ^e   Gregor, Michael ^a   Klump, Bodo ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Institute of Pathology   (Germany)

^c KLINIKUM ASCHAFFENBURG   (Germany)

^d Evangelic Hospital   (Germany)

^e Central Hospital Bremen Ost   (Germany)

Author keywords

BAT26; BAX; BAX MSI phenotype; Colon carcinoma; Microsatellite instability

Indexed keywords

PROTEIN BAX;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; COLON SURGERY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MICROSATELLITE MARKER; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PREDICTOR VARIABLE; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SINGLE STRAND CONFORMATION POLYMORPHISM; SURVIVAL TIME;

AGED; BCL-2-ASSOCIATED X PROTEIN; COLONIC NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM STAGING; PHENOTYPE; PROGNOSIS;

EID: 67349213603     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-009-0635-0     Document Type: Article

References (33)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics 2007. CA Cancer J Clin 57:43-66
2. Gill S, Loprinzi CL, Sargent DJ, Thomé SD, Alberts SR, Haller DG, Benedetti J, Francini G, shepherd LE, Seitz JF, Labianca R, Chen W, Cha SS, Heldebrant MP, Goldberg RM (2004) Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 22:1797-1806
3. Wolpin BM, Meyerhardt JA, Mamon HJ, Mayer RJ (2007) Adjuvant treatment for colorectal cancer. CA Cancer J Clin 57:168-185
4. Lindmark G, Bergström R, Pahlmann L, Glimelius B (1995) The association of preoperative serum tumor markers with Duke's stage and survival in colorectal cancer. Br J Cancer 71:1090-1094
5. Greene FL, Stewart AK, Norton J (2002) A new TNM staging strategy for node positive (stage III) colon cancer. Ann Surg 4:416-421
6. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759-767
7. Perucho M (1996) Cancer of the microsatellite mutator phenotype. Biol Chem 377:675-684
8. Popat S, Hubner R, Houlston RS (2005) Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 23:609-618
9. Kerr J, Wyllie A, Currie A (1972) Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 26:239-257
10. Miyashita T, Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299
11. Hoang JM, Cottu PH, Thuille B, Salmon RJ, Thomas G, Hamelin R (1997) BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res 57:300-303
12. Loukola A, Eklin K, Laiho P, Solovaara R, Kristo P, Järvinen H, Mecklin JP, Launonen V, Aaltonen LA (2001) Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC). Cancer Res 61:4545-4549
13. Jansson A, Sun XF (2002) BAX expression decreases significantly from primary tumor to metastasis in colorectal cancer. J Clin Oncol 20:811-816
14. Söreide K, Janssen EAM, Söiland H, Körner H, Baak JPA (2006) Microsatellite instability in colorectal cancer. Br J Surgery 93:395-406
15. Sturm I, Ko7die;hne CH, Wolff G, Petrowsky H, Hillebrand T, Hauptmann S, Lorenz M, Dorken P, Daniel PT (1999) Analysis of the p53/BAX pathway in colorectal cancer: Low BAX is a negative prognostic factor in patients with resected liver metastases. J Clin Oncol 17:1364-1374
16. Schelwies K, Sturm I, Grabowski P, Scherubl H, Schindler I, Hermann S, Stein H, Buhr HJ, Riecken EO, Zeitz M, Dorken P, Daniel PT (2002) Analysis of p53/BAX in primary colorectal carcinoma: Low BAX protein expression is a negative prognostic factor in UICC stage III tumours. Int J Cancer 99:589-596
17. Nehls O, Okech T, Hsieh CJ, Sarbia M, Borchard F, Gruenagel HH, Gaco V, Porschen R, Gregor M, Klump B (2005) Low BAX protein expression correlates with disease-recurrence in preoperatively irradiated rectal carcinoma. Int J Radiat Oncol Biol Phys 61:85-91
18. Nehls O, Okech T, Hsieh CJ, Enzinger T, Sarbia M, Borchard F, Gruenagel HH, Gaco V, Hass HG, Arkenau HAT, Hartmann JT, Porschen R, Gregor M, Klump B (2007) Studies on p53, BAX, and Bcl-2 protein expression in stage III (UICC) colon cancer treated by adjuvant chemotherapy: Major prognostic impact of proapoptotic BAX pronounced by intact p53. Br J Cancer 96:1409-1418
19. Sobin LH, Wittekind C (1997) TNM Classification of Malignant Tumours. UICC, International Union against cancer, 5th edn. Wiley-Liss, New York
20. Giatromanolaki A, Sivridis E, Stathopoulos GP, Fountzilas G, Kalofonos HP, Tsamandas A, Vrettou E, Scopa C, Polychronidis A, Simopoulos K, Koukourakis MI (2001) Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse. Anticancer Res 21:253-259
21. Koda M, Reszec J, Sulkowska M, Kanczuga-Koda L, Sulkowski S (2004) Expression of the insulin-like growth factor-I receptor and proapoptotic BAX and Bak proteins in human colorectal cancer. Ann N Y Acad Sci 1030:377-383
22. Backus HHJ, van Groeningen CJ, Vos W, Dukers DF, Bloemena E, Wouters D, Pinedo HM, Peters GJ (2004) Differential expression of cell cycle and apoptosis related proteins in colorectal mucosa, primary colon tumours, and liver metastases. J Clin Pathol 55:206-211
23. Elsaleh H, Powell B, McCaul K, Grieu F, Grant R, Joseph D, Iacopetta B (2001) P53 alterations and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma. Clin Cancer Res 7:1343-1349
24. Evertson S, Wallin A, Arbman G, Rütten S, Emterling A, Zhang H, Sun XF (2003) Microsatellite instability and MBD4 mutation in unselected colorectal cancer. Anticancer Res 23:3569-3574
25. Wang C, van Rijnsoever M, Grieu F, Bydder S, Elsaleh H, Joseph D, Harvey J, Iacopetta B (2003) Prognostic significance of microsatellite instability and Ki-ras mutation type in stage II colorectal cancer. Oncology 64:259-265
26. Minamoto T, Esumi H, Ochiai A, Belitsky G, Mai M, Sugimura T, Ronai Z (1997) Combined analysis of microsatellite instability and k-ras mutation increases detection of normal samples from colorectal cancer patients. Clin Cancer Res 3:1413-1417
27. Gryfe R, Kim H, Hsieh ET, Aronson MD, Holowaty EJ, Bull SB, Redston M, Gallinger S (2000) Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. New Engl J Med 342:69-77
28. Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, Hamilton SR, Laurent-Puig P, Gryfe R, Shepherd LE, Tu D, Redston M, Gallinger S (2003) Tumor microsatellite instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. New Engl J Med 349:247-257
29. Nakata B, Muguruma K, Hirakawa K, Chung YS, Yamashita Y, Inoue T, Matsuoka T, Onoda N, Kato Y, Sowa M (1998) Predictive value of Bcl-2 and BAX protein expression for chemotherapeutic effect in gastric cancer. A pilot study. Oncology 55:543-547
30. Kang SY, Han JH, Lee KJ, Choi J-H, Park JI, Kim HI, Lee H-W, Jang JH, Park JS, Kim HC, Kang S, Oh YT, Chun M, Kim JH, Sheen SS, Lim H-Y (2007) Low expression of BAX predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy. Clin Cancer Res 13:4146-4153
31. Theodorakis P, Lomonosova E, Chinnadurai G (2002) Critical requirement of BAX manifestation of apoptosis induced by multiple stimuli in human epithelial cancer cell lines. Cancer Res 62:3373-3376
32. Schrag D, Cramer LD, Bach PB, Cohen AM, Warren JL, Begg CB (2000) Influence of hospital procedure volume on outcomes following surgery for colon cancer. JAMA 284:3028-3035
33. Rabeneck L, Davila JA, Thompson M, El-Serag HB (2004) Surgical volume and long-term survival following surgery for colorectal cancer in the Veterans Affairs Health-Care System. Am J Gastroenterol 99:668-675